
Sign up to save your podcasts
Or
Here we provide a comprehensive overview of Alzheimer's disease (AD) research, tracing its evolution from its initial discovery to current and future directions. This resource explains how AD was historically misunderstood as a rare condition before being redefined as a major public health crisis, leading to the development of the amyloid cascade hypothesis as a dominant theory. This resources details the challenges and failures of early anti-amyloid drug trials, which ultimately broadened scientific understanding beyond a single-target approach. Crucially, the resource highlights recent breakthroughs in disease-modifying therapies like lecanemab and donanemab, alongside a revolution in diagnostics through advanced imaging and blood tests. Finally, it explores the future of AD research, focusing on prevention, combination therapies, and precision medicine, acknowledging the disease's multifaceted nature.
Here we provide a comprehensive overview of Alzheimer's disease (AD) research, tracing its evolution from its initial discovery to current and future directions. This resource explains how AD was historically misunderstood as a rare condition before being redefined as a major public health crisis, leading to the development of the amyloid cascade hypothesis as a dominant theory. This resources details the challenges and failures of early anti-amyloid drug trials, which ultimately broadened scientific understanding beyond a single-target approach. Crucially, the resource highlights recent breakthroughs in disease-modifying therapies like lecanemab and donanemab, alongside a revolution in diagnostics through advanced imaging and blood tests. Finally, it explores the future of AD research, focusing on prevention, combination therapies, and precision medicine, acknowledging the disease's multifaceted nature.